logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Mobocertinib CAS 1847461-43-1

Mobocertinib CAS 1847461-43-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1847461-43-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1847461-43-1
Appearance::
Pale Yellow Solid Powder
Molecular Formula::
C32H39N7O4
Molecular Weight::
585.70
EINECS NO::
NA
MDL NO::
NA
CAS NO::
1847461-43-1
Appearance::
Pale Yellow Solid Powder
Molecular Formula::
C32H39N7O4
Molecular Weight::
585.70
EINECS NO::
NA
MDL NO::
NA
Mobocertinib CAS 1847461-43-1

Product Description:

Product Name: mobocertinib CAS NO: 1847461-43-1

 

 

 

Synonyms:

AP 32788;

TAK-788;

 

 

 

Chemical & Physical Properties:

Appearance: Pale yellow solid powder

Assay: ≥99.0%

Solubility: DMSO ≥ 8 mg/Ml

Storage: at -20℃

 

 

 

 

Safety Information:

Signal Word: Warning

Hazard Statements: H302; H315; H319; H335

Precautionary Statements: P261; P305+P351+P338

 

 

 

Mobocertinib (TAK-788) is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions. Mobocertinib (TAK-788) inhibits all 14 mutant variants of EGFR (IC50s=2.4-22 nM), and all 6 mutant variants of HER2 (IC50s=2.4-26 nM), more potently than it inhibited WT EGFR (IC50=35 nM). Daily oral dosing of Mobocertinib in mice implanted with a patient-derived tumor containing an EGFR exon 20 activating insertion induced regression of tumors at doses that were well tolerated (30-100 mg/kg).

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.